After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Merus N.V is $3.26B. A total of 1.16 million shares were traded on the day, compared to an average of 609.94K shares.
In the most recent transaction, Shuman Harry sold 2,500 shares of MRUS for 54.00 per share on Aug 21 ’24. After the transaction, the VP Controller, PAO now owns 7,002 company shares. In a previous transaction on Aug 20 ’24, Shuman Harry sold 2,500 shares at 54.00 per share. MRUS shares that VP Controller, PAO owns now total 7,002.
Among the insiders who sold shares, Silverman Peter B. disposed of 10,000 shares on Jun 27 ’24 at a per-share price of $60.00. This resulted in the COO & GC holding 0 shares of MRUS after the transaction. In another insider transaction, Silverman Peter B. sold 62,000 shares at $56.52 per share on Jun 17 ’24. Company shares held by the COO & GC now total 0.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MRUS has a high of $61.61 and a low of $37.77.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MRUS’s latest balance sheet shows that the firm has $410.43M in Cash & Short Term Investments as of fiscal 2021. There were $3.75M in debt and $71.90M in liabilities at the time. Its Book Value Per Share was $10.28, while its Total Shareholder’s Equity was $316.20M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRUS is Buy with a score of 4.94.
